Skip to content

Comparison of two class of drugs in controlling fast heart rate in arrhythmia

Beta blockers vs Calcium channel blockers for rate control in Atrial Fibrillation with fast ventricular rate:A randomised open labelled study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075156
Enrollment
60
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I489- Unspecified atrial fibrillation and atrial flutter

Interventions

Intervention1: Calcium channel blocker(Diltiazem): Diltiazem is given at 0.25mg/kg(max-20mg) intravenously followed by 0.35 mg/kg(max-30mg) after 15 mins to see response in heart rate Control Interven

Sponsors

Department of Emergency MedicineAIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All hemodynamically stable patients presenting to ED with ECG showing Atrial fibrillation with fast ventricular rate more than 110 beats per minute,consenting for study

Exclusion criteria

Exclusion criteria: 1.pregnancy 2.systolic blood pressure less than 90mm of mercury 3.heart rate more than 220 beats per minute 4.QRS duration more than 120 milliseconds 5.Febrile patients with temperature more than 38 celsius 6.ECG suggestive of acute ST elevation Myocardial infarction 7.History of allergy to Diltiazem or Metoprolol 8.Acute decompensated heart failure patients with ejection fraction less than 40% or NYHA class 3,4 or patients with active wheezing or history of Bronchial asthma and Chronic obstructive pulmonary disease

Design outcomes

Primary

MeasureTime frame
To compare the effects of Metoprolol versus Diltiazem in decreasing heart rate to less than 110 beats per minute or 20% reduction of initial heart rate within 30 minutes of drug intakeTimepoint: The outcome of drug intake are estimated after 30 minutes.

Secondary

MeasureTime frame
To evaluate the incidence of hypotension(systolic blood pressure to less than 90 mm of mercury) and bradycardia (heart rate less than 60 beats per minute)Timepoint: within 30 minutes of drug administration;To evaluate the incidence of length of ED stayTimepoint: Within 30 minutes of drug administration;To evaluate the incidence of requirement of second dose of same medication or subsequent doses of other class medication for rate controlTimepoint: Within 30 minutes of drug administration

Countries

India

Contacts

Public ContactDr Anil Akhil

AIIMS New Delhi

ranjan.prakashmishra@gmail.com8826118924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026